MX9603690A - Tableta de paracetamol y domperidona, revestida con pelicula. - Google Patents

Tableta de paracetamol y domperidona, revestida con pelicula.

Info

Publication number
MX9603690A
MX9603690A MX9603690A MX9603690A MX9603690A MX 9603690 A MX9603690 A MX 9603690A MX 9603690 A MX9603690 A MX 9603690A MX 9603690 A MX9603690 A MX 9603690A MX 9603690 A MX9603690 A MX 9603690A
Authority
MX
Mexico
Prior art keywords
domperidone
paracetamol
film coated
coated tablet
agent
Prior art date
Application number
MX9603690A
Other languages
English (en)
Inventor
Gordon Prudhoe
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8216670&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9603690(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX9603690A publication Critical patent/MX9603690A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Piezo-Electric Or Mechanical Vibrators, Or Delay Or Filter Circuits (AREA)

Abstract

La presente invencion se refiere a una tableta revestida con película que comprende como ingredientes activos el agente analgésico paracetamol y el agente antiemético domperidona, y a un procedimiento para preparar dicha tableta.
MX9603690A 1994-02-28 1995-02-27 Tableta de paracetamol y domperidona, revestida con pelicula. MX9603690A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94200498 1994-02-28
PCT/EP1995/000719 WO1995022974A2 (en) 1994-02-28 1995-02-27 Film coated tablet of paracetamol and domperidone

Publications (1)

Publication Number Publication Date
MX9603690A true MX9603690A (es) 1997-06-28

Family

ID=8216670

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9603690A MX9603690A (es) 1994-02-28 1995-02-27 Tableta de paracetamol y domperidona, revestida con pelicula.

Country Status (30)

Country Link
US (1) US5814339A (es)
EP (1) EP0749308B1 (es)
JP (1) JP2931409B2 (es)
KR (1) KR100202154B1 (es)
CN (1) CN1084616C (es)
AT (1) ATE240102T1 (es)
AU (1) AU703242B2 (es)
BR (1) BR9506903A (es)
CA (1) CA2182004C (es)
CY (1) CY2383B1 (es)
CZ (1) CZ291999B6 (es)
DE (1) DE69530759T2 (es)
DK (1) DK0749308T3 (es)
ES (1) ES2199982T3 (es)
FI (1) FI117373B (es)
HK (1) HK1010687A1 (es)
HU (1) HU228149B1 (es)
IL (1) IL112802A (es)
MX (1) MX9603690A (es)
MY (1) MY115433A (es)
NO (1) NO309455B1 (es)
NZ (1) NZ281236A (es)
PL (1) PL179080B1 (es)
PT (1) PT749308E (es)
RU (1) RU2153337C2 (es)
SI (1) SI0749308T1 (es)
SK (1) SK282506B6 (es)
TW (1) TW466119B (es)
WO (1) WO1995022974A2 (es)
ZA (1) ZA951616B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9710767D0 (en) * 1996-06-26 1997-07-23 On Ninh Analgesic and anti-inflamatory compositions comprising domperidone and methods of using same
GB9816899D0 (en) 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
US20030072731A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
GB2443793B (en) * 2006-04-05 2010-12-01 Reckitt Benckiser Healthcare Product, method of manufacture and use
WO2008134540A1 (en) * 2007-04-26 2008-11-06 Aronchick Craig A Compositions and methods for transmucosal delivery of domperidone
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
EP2217213B1 (en) * 2007-10-31 2017-05-24 Johnson & Johnson Consumer Inc. Orally disintegrative dosage form
US8784781B2 (en) 2009-09-24 2014-07-22 Mcneil-Ppc, Inc. Manufacture of chewing gum product with radiofrequency
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
FR2992218B1 (fr) * 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN106068120B (zh) 2014-01-10 2021-03-23 强生消费者公司 使用射频和有损耗的包衣粒子制造片剂的方法
CN113995755A (zh) * 2016-02-04 2022-02-01 辛多美制药有限公司 氘代多潘立酮组合物和用于治疗病症的方法
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
KR20240125702A (ko) 2017-06-30 2024-08-19 신돔 파마, 인크. 중수소화 돔페리돈 조성물, 방법, 및 제조
CN110302169A (zh) * 2019-08-01 2019-10-08 张慧芬 一种滑膜衣片剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU528098B2 (en) * 1978-11-16 1983-04-14 Beecham Group Plc Analgesic tablet
CA2020018A1 (en) * 1990-06-27 1991-12-28 Don L. Simmons Method and composition for treating the migraine complex
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
CA2139638A1 (en) * 1992-07-07 1994-01-20 Nancy M. Gray Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
TW272942B (es) * 1993-02-10 1996-03-21 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
DK0749308T3 (da) 2003-09-01
DE69530759D1 (de) 2003-06-18
FI117373B (fi) 2006-09-29
HK1010687A1 (en) 1999-06-25
JP2931409B2 (ja) 1999-08-09
HU9601384D0 (en) 1996-07-29
ZA951616B (en) 1996-08-27
HU228149B1 (en) 2012-12-28
EP0749308B1 (en) 2003-05-14
SK103296A3 (en) 1997-03-05
CZ225596A3 (en) 1996-11-13
IL112802A (en) 1999-08-17
US5814339A (en) 1998-09-29
PT749308E (pt) 2003-10-31
HUT74477A (en) 1996-12-30
BR9506903A (pt) 1997-09-09
NO309455B1 (no) 2001-02-05
CN1084616C (zh) 2002-05-15
WO1995022974A2 (en) 1995-08-31
NZ281236A (en) 2001-11-30
PL314850A1 (en) 1996-09-30
SI0749308T1 (en) 2003-10-31
TW466119B (en) 2001-12-01
FI962156A (fi) 1996-06-04
FI962156A0 (fi) 1996-05-22
ATE240102T1 (de) 2003-05-15
RU2153337C2 (ru) 2000-07-27
CY2383B1 (en) 2004-06-04
PL179080B1 (pl) 2000-07-31
CN1141589A (zh) 1997-01-29
DE69530759T2 (de) 2004-03-18
ES2199982T3 (es) 2004-03-01
AU1812395A (en) 1995-09-11
CA2182004A1 (en) 1995-08-31
NO962153D0 (no) 1996-05-28
CA2182004C (en) 2000-10-31
EP0749308A1 (en) 1996-12-27
CZ291999B6 (cs) 2003-07-16
SK282506B6 (sk) 2002-10-08
IL112802A0 (en) 1995-05-26
WO1995022974A3 (en) 1995-09-21
NO962153L (no) 1996-08-26
KR100202154B1 (ko) 1999-06-15
JPH09500910A (ja) 1997-01-28
MY115433A (en) 2003-06-30
AU703242B2 (en) 1999-03-25

Similar Documents

Publication Publication Date Title
MY115433A (en) Film coated tablet of paracetamol and domperidone.
MX9604354A (es) Nueva forma de dosis farmaceutica oral.
MX9600857A (es) Forma de dosificacion i en tabletas, con unidades multiples.
GR3025550T3 (en) Extended release, film-coated tablet of astemizole and pseudoephedrine
GEP20012442B (en) Irreversible Inhibitors of Tyrosine Kinases
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
MY128809A (en) Pharmaceutical formulation of omeprazole
MXPA03006364A (es) TRATAMIENTO DE PERTURBACIONES DEL SUEnO.
HRP950414B1 (en) New compounds with analgetic and local anaesthetic effect
WO1998038994A3 (de) Kombinationspräparat aus 2-methylthiazolidin-2,4-dicarbonsäure und paracetamol
ES8304059A1 (es) Procedimiento para la preparacion de composiciones a base desalicilato de imidazol
CZ44395A3 (en) Hydroxylamines exhibiting hypoglycemic activity, process of their preparation, their use and pharmaceutical compositions containing thereof
JO1881B1 (en) Formula II for multi unit disc calibration